Date published: 2026-3-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ceramide trihexosides (CAS 71965-57-6)

0.0(0)
Write a reviewAsk a question

Alternate Names:
Globotriaosylceramide
CAS Number:
71965-57-6
Purity:
98%
Molecular Weight:
1137
Molecular Formula:
C60H113NO18
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Ceramide trihexosides are glycosphingolipids composed of a ceramide backbone with three hexose sugar molecules attached. They play crucial roles in cell membrane structure, signaling, and recognition. Research has delved into their involvement in cellular processes and their implications in various diseases, particularly those related to lipid metabolism and neurological disorders. Studies suggest that ceramide trihexosides contribute to membrane integrity and stability, modulate cell signaling pathways, and participate in cell-cell interactions. Moreover, abnormalities in ceramide trihexoside metabolism have been implicated in lipid storage disorders such as Gaucher disease, where accumulation of these glycosphingolipids contributes to the pathogenesis of the disease. Additionally, research has linked ceramide trihexosides to neurological disorders like Parkinson′s disease, where altered levels of these lipids affect neuronal function and viability. Furthermore, emerging research explores the potential of ceramide trihexosides as biomarkers for disease diagnosis and progression monitoring. Understanding the mechanisms underlying ceramide trihexoside metabolism and its roles in cellular physiology and pathology opens avenues for interventions targeting lipid-related disorders and neurological conditions.


Ceramide trihexosides (CAS 71965-57-6) References

  1. Ionization and fragmentation of neutral and acidic glycosphingolipids with a Q-TOF mass spectrometer fitted with a MALDI ion source.  |  Hunnam, V., et al. 2001. J Am Soc Mass Spectrom. 12: 1220-5. PMID: 11720398
  2. Glycolipids in human lung carcinoma of histologically different types.  |  Yoda, Y., et al. 1979. J Natl Cancer Inst. 63: 1153-60. PMID: 228102
  3. Ganglioside-modulated protein phosphorylation in myelin.  |  Chan, KF. 1987. J Biol Chem. 262: 2415-22. PMID: 2434483
  4. Multiplex testing for the screening of lysosomal storage disease in urine: Sulfatides and glycosaminoglycan profiles in 40 cases of sulfatiduria.  |  Pino, G., et al. 2020. Mol Genet Metab. 129: 106-110. PMID: 31753749
  5. Polyphenol from millet bran increases the sensitivity of colorectal cancer cells to oxaliplatin by blocking the ganglioside GM3 catabolism.  |  Zhang, X., et al. 2021. Food Funct. 12: 291-301. PMID: 33300910
  6. Globotriaosylceramide-related biomarkers of fabry disease identified in plasma by high-performance thin-layer chromatography - densitometry- mass spectrometry.  |  Jarne, C., et al. 2021. J Chromatogr A. 1638: 461895. PMID: 33477028
  7. Pseudo-clinical Fabry's disease without alpha galactosidase deficiency.  |  Peltier, A., et al. 1977. Biomedicine. 26: 194-201. PMID: 407951
  8. Anomeric configuration of galactose residues in ceramide trihexosides.  |  Li, YT. and Li, SC. 1971. J Biol Chem. 246: 3769-71. PMID: 5104445
  9. The metabolism of ceramide trihexosides. I. Purification and properties of an enzyme that cleaves the terminal galactose molecule of galactosylgalactosylglucosylceramide.  |  Brady, RO., et al. 1967. J Biol Chem. 242: 1021-6. PMID: 6020428
  10. Separation of neutral glycosphingolipids and sulfatides by thin-layer chromatography.  |  Skipski, VP., et al. 1967. J Lipid Res. 8: 295-9. PMID: 6033595

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Ceramide trihexosides, 1 mg

sc-360244
1 mg
$551.00